Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Diseases of the Thyroid

  Free Subscription


Articles published in Endocr J

Retrieve available abstracts of 103 articles:
HTML format
Text format



Single Articles


    June 2018
  1. LU Q, Luo X, Mao C, Zheng T, et al
    Caveolin-1 regulates autophagy activity in thyroid follicular cells and is involved in Hashimoto's thyroiditis disease.
    Endocr J. 2018 Jun 6. doi: 10.1507/endocrj.EJ18-0003.
    PubMed     Text format     Abstract available


    May 2018
  2. OMORI N, Watanabe M, Inoue N, Taniguchi J, et al
    Association of the polymorphisms in Th2 chemotaxis-related genes with the development and prognosis of autoimmune thyroid diseases.
    Endocr J. 2018 May 30. doi: 10.1507/endocrj.EJ18-0050.
    PubMed     Text format     Abstract available


  3. TOMKINS M, Cavalcoli F, Stanley E, O'Rourke K, et al
    Autonomic alterations as a clinical manifestation of encephalopathy associated with autoimmune thyroid disease.
    Endocr J. 2018 May 25. doi: 10.1507/endocrj.EJ18-0035.
    PubMed     Text format     Abstract available


  4. TAKAMIZAWA T, Satoh T, Miyamoto T, Nakajima Y, et al
    Transducin beta-like 1, X-linked and nuclear receptor co-repressor cooperatively augment the ligand-independent stimulation of TRH and TSHbeta gene promoters by thyroid hormone receptors.
    Endocr J. 2018 May 23. doi: 10.1507/endocrj.EJ17-0384.
    PubMed     Text format     Abstract available


  5. LIU M, Li Z, Liang B, Li L, et al
    Hydrogen sulfide ameliorates rat myocardial fibrosis induced by thyroxine through PI3K/AKT signaling pathway.
    Endocr J. 2018 May 9. doi: 10.1507/endocrj.EJ17-0445.
    PubMed     Text format     Abstract available


    April 2018
  6. ITO Y, Miyauchi A, Hirokawa M, Yamamoto M, et al
    Prognostic value of the 8(th) edition of the tumor-node-metastasis classification for patients with papillary thyroid carcinoma: a single-institution study at a high-volume center in Japan.
    Endocr J. 2018 Apr 20. doi: 10.1507/endocrj.EJ18-0019.
    PubMed     Text format     Abstract available


  7. ITO Y, Miyauchi A, Hirokawa M, Yamamoto M, et al
    Prognostic value of the 8(th) tumor-node-metastasis classification for follicular carcinoma and poorly differentiated carcinoma of the thyroid in Japan.
    Endocr J. 2018 Apr 4. doi: 10.1507/endocrj.EJ17-0524.
    PubMed     Text format     Abstract available


    March 2018
  8. SUZUKI A, Hirokawa M, Ito A, Takada N, et al
    Derivation of thyroid lymphoepithelial cysts from follicular cells.
    Endocr J. 2018 Mar 14. doi: 10.1507/endocrj.EJ17-0402.
    PubMed     Text format     Abstract available


    February 2018
  9. TAKENOBU M, Moritani S, Yoshioka K, Morisaki T, et al
    A case report of thyroid metastasis from p16-positive oropharyngeal squamous cell carcinoma.
    Endocr J. 2018 Feb 15. doi: 10.1507/endocrj.EJ17-0553.
    PubMed     Text format     Abstract available


  10. HIROKAWA M, Takada N, Abe H, Suzuki A, et al
    Thyroid sclerosing mucoepidermoid carcinoma with eosinophilia distinct from the salivary type.
    Endocr J. 2018 Feb 8. doi: 10.1507/endocrj.EJ17-0462.
    PubMed     Text format     Abstract available


    January 2018
  11. HIGUCHI T, Achmad A, Binh DD, Bhattarai A, et al
    Determining patient selection tool and response predictor for outpatient 30 mCi radioiodine ablation dose in non-metastatic differentiated thyroid carcinoma: a Japanese perspective.
    Endocr J. 2018 Jan 16. doi: 10.1507/endocrj.EJ17-0343.
    PubMed     Text format     Abstract available


  12. ARICI M, Oztas E, Yanar F, Aksakal N, et al
    Association between genetic polymorphism and levothyroxine bioavailability in hypothyroid patients.
    Endocr J. 2018 Jan 11. doi: 10.1507/endocrj.EJ17-0162.
    PubMed     Text format     Abstract available


    December 2017
  13. SUGINO K, Nagahama M, Kitagawa W, Ohkuwa K, et al
    Clinical factors related to the efficacy of tyrosine kinase inhibitor therapy in radioactive iodine refractory recurrent differentiated thyroid cancer patients.
    Endocr J. 2017 Dec 21. doi: 10.1507/endocrj.EJ17-0365.
    PubMed     Text format     Abstract available


  14. SUN D, Zhou L, Wang S, Liu T, et al
    Effect of Di-(2-ethylhexyl) phthalate on the hypothalamus-pituitary-thyroid axis in adolescent rat.
    Endocr J. 2017 Dec 9. doi: 10.1507/endocrj.EJ17-0272.
    PubMed     Text format     Abstract available


  15. TAKADA N, Hirokawa M, Ohbayashi C, Nishikawa T, et al
    Re-evaluation of MIB-1 immunostaining for diagnosing hyalinizing trabecular tumour of the thyroid: semi-automated techniques with manual antigen retrieval are more accurate than fully automated techniques.
    Endocr J. 2017 Dec 2. doi: 10.1507/endocrj.EJ17-0413.
    PubMed     Text format     Abstract available


    November 2017
  16. HIROKAWA M, Nishihara E, Takada N, Higuchi M, et al
    Warthin-like papillary thyroid carcinoma with immunoglobulin G4-positive plasma cells possibly related to Hashimoto's thyroiditis.
    Endocr J. 2017 Nov 2. doi: 10.1507/endocrj.EJ17-0319.
    PubMed     Text format     Abstract available


    October 2017
  17. QU HJ, Qu XY, Hu Z, Lin Y, et al
    The synergic effect of BRAFV600E mutation and multifocality on central lymph node metastasis in unilateral papillary thyroid carcinoma.
    Endocr J. 2017 Oct 26. doi: 10.1507/endocrj.EJ17-0110.
    PubMed     Text format     Abstract available


  18. HE L, Shen C, Zhang Y, Chen Z, et al
    Evaluation of serum ferritin and thyroid function in the second trimester of pregnancy.
    Endocr J. 2017 Oct 13. doi: 10.1507/endocrj.EJ17-0253.
    PubMed     Text format     Abstract available


    September 2017
  19. HIROKAWA M, Higuchi M, Suzuki A, Hayashi T, et al
    Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a single-institutional experience in Japan.
    Endocr J. 2017 Sep 12. doi: 10.1507/endocrj.EJ17-0214.
    PubMed     Text format     Abstract available


  20. SATOH M, Aso K, Nakayama T, Saji T, et al
    Effect of treatment with epoprostenol and endothelin receptor antagonists on the development of thyrotoxicosis in patients with pulmonary arterial hypertension.
    Endocr J. 2017 Sep 9. doi: 10.1507/endocrj.EJ17-0155.
    PubMed     Text format     Abstract available


  21. SUZUKI A, Hirokawa M, Takada N, Higuchi M, et al
    Fine-needle aspiration cytology for medullary thyroid carcinoma: a single institutional experience in Japan.
    Endocr J. 2017 Sep 5. doi: 10.1507/endocrj.EJ17-0238.
    PubMed     Text format     Abstract available


  22. AOYAMA M, Takizawa H, Tsuboi M, Nakagawa Y, et al
    A case of metastatic follicular thyroid carcinoma complicated with Graves' disease after total thyroidectomy.
    Endocr J. 2017 Sep 5. doi: 10.1507/endocrj.EJ17-0220.
    PubMed     Text format     Abstract available


  23. NARUMI S, Fox LA, Fukudome K, Sakaguchi Z, et al
    Mild thyroid peroxidase deficiency caused by TPO mutations with residual activity: Correlation between clinical phenotypes and enzymatic activity.
    Endocr J. 2017 Sep 1. doi: 10.1507/endocrj.EJ17-0194.
    PubMed     Text format     Abstract available


    August 2017
  24. SAWA A, Chiba T, Ishii J, Yamamoto H, et al
    Effects of sorafenib and an adenylyl cyclase activator on in vitro growth of well-differentiated thyroid cancer cells.
    Endocr J. 2017 Aug 31. doi: 10.1507/endocrj.EJ16-0525.
    PubMed     Text format     Abstract available


  25. WU W, Gong X, Zhou Q, Chen X, et al
    US-guided percutaneous microwave ablation for the treatment of benign thyroid nodules.
    Endocr J. 2017 Aug 29. doi: 10.1507/endocrj.EJ17-0152.
    PubMed     Text format     Abstract available


  26. TOMARI S, Watanabe M, Inoue N, Mizuma T, et al
    The polymorphisms in the thyroid peroxidase gene were associated with the development of autoimmune thyroid disease and the serum levels of TPOAb.
    Endocr J. 2017 Aug 25. doi: 10.1507/endocrj.EJ17-0191.
    PubMed     Text format     Abstract available


  27. TAKADA N, Hirokawa M, Ito M, Ito A, et al
    Papillary thyroid carcinoma with desmoid-type fibromatosis: A clinical, pathological, and immunohistochemical study of 14 cases.
    Endocr J. 2017 Aug 10. doi: 10.1507/endocrj.EJ17-0242.
    PubMed     Text format     Abstract available


  28. BOGDANOVA TI, Saenko VA, Hirokawa M, Ito M, et al
    Comparative histopathological analysis of sporadic pediatric papillary thyroid carcinoma from Japan and Ukraine.
    Endocr J. 2017 Aug 10. doi: 10.1507/endocrj.EJ17-0134.
    PubMed     Text format     Abstract available


  29. NISHIHARA E, Amino N, Kudo T, Ito M, et al
    Comparison of thyroglobulin and thyroid peroxidase antibodies measured by five different kits in autoimmune thyroid diseases.
    Endocr J. 2017 Aug 2. doi: 10.1507/endocrj.EJ17-0164.
    PubMed     Text format     Abstract available


    July 2017
  30. HIROKAWA M, Kudo T, Ota H, Suzuki A, et al
    Preoperative diagnostic algorithm of primary thyroid lymphoma using ultrasound, aspiration cytology, and flow cytometry.
    Endocr J. 2017 Jul 8. doi: 10.1507/endocrj.EJ17-0111.
    PubMed     Text format     Abstract available


  31. HIROKAWA M, Miyauchi A, Kihara M, Kudo T, et al
    Chromophobe renal cell carcinoma-like thyroid carcinoma: A novel clinicopathologic entity possibly associated with tuberous sclerosis complex.
    Endocr J. 2017 Jul 6. doi: 10.1507/endocrj.EJ17-0096.
    PubMed     Text format     Abstract available


    June 2017
  32. MASAKI C, Sugino K, Saito N, Saito Y, et al
    Lenvatinib induces early tumor shrinkage in patients with advanced thyroid carcinoma.
    Endocr J. 2017 Jun 28. doi: 10.1507/endocrj.EJ17-0104.
    PubMed     Text format     Abstract available


  33. SUGISAWA C, Higuchi S, Takagi M, Hasegawa Y, et al
    Homozygous DUOXA2 mutation (p.Tyr138*) in a girl with congenital hypothyroidism and her apparently unaffected brother: Case report and review of the literature.
    Endocr J. 2017 Jun 16. doi: 10.1507/endocrj.EJ16-0564.
    PubMed     Text format     Abstract available


  34. TAKADA N, Hirokawa M, Suzuki A, Higuchi M, et al
    Reappraisal of "cyst fluid only" on thyroid fine-needle aspiration cytology.
    Endocr J. 2017 Jun 13. doi: 10.1507/endocrj.EJ17-0082.
    PubMed     Text format     Abstract available


  35. XIN W, Yu Y, Ma Y, Gao Y, et al
    Thyroid-stimulating hormone stimulation downregulates autophagy and promotes apoptosis in chondrocytes.
    Endocr J. 2017 Jun 13. doi: 10.1507/endocrj.EJ16-0534.
    PubMed     Text format     Abstract available


    May 2017
  36. INOUE N, Watanabe M, Nakaguchi A, Ueda D, et al
    Functional polymorphisms affecting Th1 differentiation are associated with the severity of autoimmune thyroid diseases.
    Endocr J. 2017 May 16. doi: 10.1507/endocrj.EJ16-0551.
    PubMed     Text format     Abstract available


    April 2017
  37. HIGUCHI S, Takagi M, Hasegawa Y
    Use of liothyronine without levothyroxine in the treatment of mild consumptive hypothyroidism caused by hepatic hemangiomas.
    Endocr J. 2017 Apr 18. doi: 10.1507/endocrj.EJ16-0559.
    PubMed     Text format     Abstract available


  38. KE W, Sun T, Zhang Y, He L, et al
    25-Hydroxyvitamin D serum level in Hashimoto's thyroiditis, but not Graves' disease is relatively deficient.
    Endocr J. 2017 Apr 11. doi: 10.1507/endocrj.EJ16-0547.
    PubMed     Text format     Abstract available


    March 2017
  39. LI X, Zhen D, Zhao M, Liu L, et al
    Natural history of mild subclinical hypothyroidism in a middle-aged and elderly Chinese population: a prospective study.
    Endocr J. 2017 Mar 7. doi: 10.1507/endocrj.EJ16-0549.
    PubMed     Text format     Abstract available


  40. YALCIN MM, Altinova AE, Cavnar B, Bolayir B, et al
    Is thyroid autoimmunity itself associated with psychological well-being in euthyroid Hashimoto's thyroiditis?
    Endocr J. 2017 Mar 4. doi: 10.1507/endocrj.EJ16-0418.
    PubMed     Text format     Abstract available


    February 2017
  41. AKEHI Y, Hashimoto Y, Meren J, Tanabe M, et al
    Postpartum hypothalamic adrenal insufficiency with remission: A rare case.
    Endocr J. 2017;64:157-162.
    PubMed     Text format     Abstract available


  42. TAKANO T
    Natural history of thyroid cancer [Review].
    Endocr J. 2017 Feb 2. doi: 10.1507/endocrj.EJ17-0026.
    PubMed     Text format     Abstract available


    January 2017
  43. HIROKAWA M, Kudo T, Ota H, Suzuki A, et al
    Errata:Preoperative diagnostic algorithm of primary thyroid lymphoma using ultrasound, aspiration cytology, and flow cytometry [Endocrine Journal Vol. 64 (9): 859-865, 2017].
    Endocr J. 2017;64:1041-1042.
    PubMed     Text format     Abstract available


    December 2016
  44. KIM JW, Woo YJ, Yoon JS
    Is modified clinical activity score an accurate indicator of diplopia progression in Graves' orbitopathy patients?
    Endocr J. 2016;63:1133-1140.
    PubMed     Text format     Abstract available


  45. NOMURA R, Miyai K, Kuge R, Okura T, et al
    Free T3 to free T4 ratio less than 2.0 suggests low T3 syndrome rather than central hypothyroidism from the age of two to eighteen years.
    Endocr J. 2016 Dec 22. doi: 10.1507/endocrj.EJ16-0169.
    PubMed     Text format     Abstract available


    November 2016
  46. KOBAYASHI S, Yoshimura Noh J, Shimizu T, Sato T, et al
    A case of familial dysalbuminemic hyperthyroxinemia (FDH) in Japan: FDH as a possible differential diagnosis of syndrome of inappropriate secretion of thyroid-stimulating hormone (SITSH).
    Endocr J. 2016.
    PubMed     Text format     Abstract available


  47. ITO Y, Hirokawa M, Miyauchi A, Kihara M, et al
    Diagnosis and surgical indications of oxyphilic follicular tumors in Japan: Surgical specimens and cytology.
    Endocr J. 2016;63:977-982.
    PubMed     Text format     Abstract available


  48. HE Y, Mu K, Liu R, Zhang J, et al
    Comparison of two different regimens of intravenous methylprednisolone for patients with moderate to severe and active Graves' ophthalmopathy: a prospective, randomized controlled trial.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


    October 2016
  49. SATOH T, Isozaki O, Suzuki A, Wakino S, et al
    2016 Guidelines for the management of thyroid storm from The Japan Thyroid Association and Japan Endocrine Society (First edition).
    Endocr J. 2016.
    PubMed     Text format     Abstract available


    September 2016
  50. ODA H, Miyauchi A, Ito Y, Sasai H, et al
    Comparison of the costs of active surveillance and immediate surgery in the management of low-risk papillary microcarcinoma of the thyroid.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


  51. YOSHIHARA A, Yoshimura Noh J, Mukasa K, Watanabe N, et al
    The characteristics of osteoporotic patients in Graves' disease patients newly diagnosed after menopause: a prospective observational study.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


    August 2016
  52. AN JH, Kim SG
    L-carnitine supplementation in hypothyroidism [Letter to the Editor].
    Endocr J. 2016.
    PubMed     Text format    


  53. BENVENGA S, Sindoni A
    L-carnitine supplementation for the management of fatigue in patients with hypothyroidism on levothyroxine treatment [Letter to the Editor].
    Endocr J. 2016.
    PubMed     Text format    


  54. SHINOHARA S, Kikuchi M, Harada H, Takebayashi S, et al
    The influence of American Society of Anesthesiologists Physical Status on patient morbidity and survival after total thyroidectomy.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


    July 2016
  55. ITO Y, Hirokawa M, Miyauchi A, Masuoka H, et al
    Prognostic impact of Ki-67 labeling index in minimally invasive follicular thyroid carcinoma.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


  56. AN JH, Kim YJ, Kim KJ, Kim SH, et al
    L-carnitine supplementation for the management of fatigue in patients with hypothyroidism on levothyroxine treatment: a randomized, double-blind, placebo-controlled trial.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


  57. IDE A, Amino N, Nishihara E, Kudo T, et al
    Partial prediction of postpartum Graves' thyrotoxicosis by sensitive bioassay for thyroid-stimulating antibody measured in early pregnancy.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


  58. HIROKAWA M, Kudo T, Ota H, Suzuki A, et al
    Pathological characteristics of low-risk papillary thyroid microcarcinoma with progression during active surveillance.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


    June 2016
  59. MATSUZAWA K, Izawa S, Okura T, Fujii S, et al
    Implications of FoxP3-positive and -negative CD4+ CD25+ T cells in Graves' ophthalmopathy.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


  60. LESMANA R, Iwasaki T, Iizuka Y, Amano I, et al
    The change in thyroid hormone signaling by altered training intensity in male rat skeletal muscle.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


  61. UEDA-SAKANE Y, Kanamoto N, Fushimi Y, Tanaka-Mizuno S, et al
    Overall safety and efficacy of high-dose and low-dose intravenous glucocorticoid therapy in patients with moderate-to-severe active Graves' ophthalmopathy.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


    May 2016
  62. CAI TT, Zhang J, Wang X, Song RH, et al
    Gene-gene and gene-sex epistatic interactions of DNMT1, DNMT3A and DNMT3B in autoimmune thyroid disease.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


  63. ITO Y, Suzuki S, Ito KI, Imai T, et al
    Tyrosine-kinase inhibitors to treat radioiodine-refracted, metastatic, or recurred and progressive differentiated thyroid carcinoma [Review].
    Endocr J. 2016.
    PubMed     Text format     Abstract available


    April 2016
  64. KAGAWA T, Watanabe M, Inoue N, Otsu H, et al
    Increases of microRNA let-7e in peripheral blood mononuclear cells in Hashimoto's disease.
    Endocr J. 2016;63:375-80.
    PubMed     Text format     Abstract available


  65. KIHARA M, Miyauchi A, Kudo T, Hirokawa M, et al
    Reference values of serum calcitonin with calcium stimulation tests by electrochemiluminescence immunoassay before/after total thyroidectomy in Japanese patients with thyroid diseases other than medullary thyroid carcinoma.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


  66. ITO Y, Miyauchi A, Kihara M, Kudo T, et al
    Calcitonin doubling time in medullary thyroid carcinoma after the detection of distant metastases keenly predicts patients' carcinoma death.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


  67. CHACHAMOVITZ DS, Vigario PD, Silva SO, Teixeira LB, et al
    Does low-normal serum TSH level adversely impact cognition in elderly adults and might methimazole therapy improve outcomes?
    Endocr J. 2016.
    PubMed     Text format     Abstract available


    March 2016
  68. TRIMBOLI P, Centanni M, Virili C
    Liquid liothyronine to obtain target TSH in differentiated thyroid cancer patients.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


  69. LEE YS, Chang HS, Park CS
    Changing trends in the management of well-differentiated thyroid carcinoma in Korea.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


  70. MUSSAZHANOVA Z, Akazawa Y, Matsuda K, Shichijo K, et al
    Association between p53-binding protein 1 expression and genomic instability in oncocytic follicular adenoma of the thyroid.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


    February 2016
  71. SUZUKI S, Yamashita S, Fukushima T, Nakano K, et al
    The protocol and preliminary baseline survey results of the thyroid ultrasound examination in Fukushima.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


  72. ONO Y, Fujita M, Ono S, Ogata S, et al
    A rabbit model of fatal hypothyroidism mimicking "myxedema coma" established by microscopic total thyroidectomy.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


  73. KIM BY, Mok JO, Kang SK, Jang SY, et al
    The relationship between serum adipocytokines and Graves' ophthalmopathy: A hospital-based study.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


  74. CAI J, Fang Y, Jing D, Xu S, et al
    Reference intervals of thyroid hormones in a previously iodine-deficient but presently more than adequate area of Western China: a population-based survey.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


  75. HIROKAWA M, Sugitani I, Kakudo K, Sakamoto A, et al
    Histopathological analysis of anaplastic thyroid carcinoma cases with long-term survival: A report from the Anaplastic Thyroid Carcinoma Research Consortium of Japan.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


    January 2016
  76. TRIMBOLI P, Nigri G, Guidobaldi L, Romanelli F, et al
    Early diagnosis by FNA cytology should not influence the outcome of differentiated thyroid cancer.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


  77. KIM GR, Shin JH, Hahn SY, Ko EY, et al
    Ultrasonographic features and clinical characteristics of Warthin-like variant of papillary thyroid carcinoma.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


  78. MORITANI S
    Impact of superior mediastinal metastasis on the prognosis of papillary thyroid carcinoma.
    Endocr J. 2016.
    PubMed     Text format     Abstract available


    December 2015
  79. TOMODA C, Ogimi Y, Saito F, Masaki C, et al
    Outcome and characteristics of patients with malignant pleural effusion from differentiated thyroid carcinoma.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


  80. HASHIMOTO K, Tagami T, Yamakage H, Muranaka K, et al
    Serum free thyroxine levels is associated with the efficacy of weight reduction therapy in obese female patients.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


  81. YOSHIOKA W, Miyauchi A, Ito M, Kudo T, et al
    Kinetic analyses of changes in serum TSH receptor antibody values after total thyroidectomy in patients with Graves' disease.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


  82. ITO Y, Oda H, Miyauchi A
    Insights and clinical questions about the active surveillance of low-risk papillary thyroid microcarcinomas [Review].
    Endocr J. 2015.
    PubMed     Text format     Abstract available


    November 2015
  83. UCHIDA T, Suzuki R, Kasai T, Onose H, et al
    Cutoff value of thyroid uptake of Tc-pertechnetate to discriminate between Graves' disease and painless thyroiditis: a single center retrospective study.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


  84. MUKASA K, Yoshimura Noh J, Kouzaki A, Ohye H, et al
    TSH receptor antibody titers measured with a third-generation assay did not reflect the activity of Graves' ophthalmopathy in untreated Japanese Graves' disease patients.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


  85. YOSHIE N, Watanabe M, Inoue N, Kawaguchi H, et al
    Association of polymorphisms in the ICOS and ICOSL genes with the pathogenesis of autoimmune thyroid diseases.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


  86. KUNII Y, Uruno T, Mukasa K, Sekiya K, et al
    Inhibitory effect of low-dose inorganic iodine on thyroidal radioactive iodine uptake in healthy Japanese adults.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


    October 2015
  87. OZKAN C, Akturk M, Altinova AE, Cerit ET, et al
    Proprotein convertase subtilisin/kexin type 9 (PCSK9), soluble lectin-like oxidized LDL receptor 1 (sLOX-1) and ankle brachial index in patients with differentiated thyroid cancer.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


  88. KAMMORI M, Fukumori T, Sugishita Y, Hoshi M, et al
    Radioactive iodine (RAI) therapy for distantly metastatic differentiated thyroid cancer (DTC) in juvenile versus adult patients.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


    September 2015
  89. HIRATSUKA I, Itoh M, Yamada H, Yamamoto K, et al
    Simultaneous measurement of serum chemokines in autoimmune thyroid diseases: possible role of IP-10 in the inflammatory response.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


  90. ISHIDO Y, Luo Y, Yoshihara A, Hayashi M, et al
    Follicular thyroglobulin enhances gene expression necessary for thyroid hormone secretion.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


  91. SUZUKI A, Hirokawa M, Takada N, Higuchi M, et al
    Diagnostic significance of PAX8 in thyroid squamous cell carcinoma.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


    July 2015
  92. GE JF, Xu YY, Li N, Zhang Y, et al
    Resveratrol improved the spatial learning and memory in subclinical hypothyroidism rat induced by hemi-thyroid electrocauterization.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


  93. YI JW, Park JY, Sung JY, Kwak SH, et al
    Genomic evidence of reactive oxygen species elevation in papillary thyroid carcinoma with Hashimoto thyroiditis.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


  94. HANAOKA M, Arata N, Sago H
    Change of maternal thyroid function in twin-twin transfusion syndrome.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


  95. TAMADA D, Kitamura T, Onodera T, Hamasaki T, et al
    Clinical significance of fluctuations in thyroid hormones after surgery for Cushing's syndrome.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


    June 2015
  96. TAKESHIMA K, Inaba H, Ariyasu H, Furukawa Y, et al
    Clinicopathological features of Riedel's thyroiditis associated with IgG4-related disease in Japan.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


    May 2015
  97. TAKESHIMA K, Ariyasu H, Inaba H, Inagaki Y, et al
    Distribution of serum immunoglobulin G4 levels in Hashimoto's thyroiditis and clinical features of Hashimoto's thyroiditis with elevated serum immunoglobulin G4 levels.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


  98. KANG S, Amino N, Kudo T, Nishihara E, et al
    Occurrence of thyroxine tablet (Thyradin S) - induced liver dysfunction in a patient with subclinical hypothyroidism.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


  99. WU H, Zhang B
    Ultrasonographic appearance of focal Hashimoto's thyroiditis: A single institution experience.
    Endocr J. 2015.
    PubMed     Text format     Abstract available


    January 2015
  100. FUKUHARA N, Horiguchi K, Nishioka H, Suzuki H, et al
    Short-term preoperative octreotide treatment for TSH-secreting pituitary adenoma.
    Endocr J. 2015;62:21-7.
    PubMed     Text format     Abstract available


  101. UEDA Y, Tagami T, Tamanaha T, Kakita M, et al
    A family of RTHbeta with p.R316C mutation presenting occasional syndrome of inappropriate secretion of TSH.
    Endocr J. 2015;62:251-60.
    PubMed     Text format     Abstract available


  102. NARUMI S, Hasegawa T
    TSH resistance revisited.
    Endocr J. 2015;62:393-8.
    PubMed     Text format     Abstract available


  103. SHIRAISHI M, Yamamoto Y, Hirooka N, Obuchi Y, et al
    A high concentration of triiodothyronine attenuates the stimulatory effect on hemin-induced erythroid differentiation of human erythroleukemia K562 cells.
    Endocr J. 2015;62:431-40.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diseases of the Thyroid is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: